Cns Pharmaceuticals Correlations

CNSP Stock

USD 0.12 0.01 7.69%

The current 90-days correlation between Cns Pharmaceuticals and ZyVersa Therapeutics is 0.09 (i.e., Significant diversification). The correlation of Cns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cns Pharmaceuticals Correlation With Market

Average diversification

The correlation between Cns Pharmaceuticals and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cns Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Cns Stock, please use our How to Invest in Cns Pharmaceuticals guide.

Moving together with Cns Stock

0.67	VALN	Valneva SE ADR	Pair Corr
0.76	FDMT	4D Molecular Therapeutics	Pair Corr
0.64	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.62	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.67	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.68	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.75	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.68	RGNX	Regenxbio	Pair Corr
0.68	ADAP	Adaptimmune Therapeutics	Pair Corr

Moving against Cns Stock

0.7	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.65	GILD	Gilead Sciences	Pair Corr
0.54	LPCN	Lipocine	Pair Corr
0.54	NAMS	NewAmsterdam Pharma	Pair Corr
0.45	OPT	Opthea	Pair Corr
0.42	ESLAW	Estrella Immunopharma	Pair Corr
0.34	PHVS	Pharvaris BV	Pair Corr
0.69	AVTE	Aerovate Therapeutics	Pair Corr
0.62	CRVS	Corvus Pharmaceuticals	Pair Corr
0.58	ABEO	Abeona Therapeutics	Pair Corr
0.57	CDXS	Codexis	Pair Corr
0.5	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.41	VREX	Varex Imaging Corp	Pair Corr

Related Correlations Analysis

	ZVSA	EFTR	VECT	AVRO	IMMX	NAVB	SONN	CWBR	OCEA	ENVB
ZVSA		0.47	-0.73	-0.77	0.25	0.52	0.81	-0.5	0.9	0.73	ZVSA
EFTR	0.47		-0.44	-0.26	0.5	0.57	0.24	-0.28	0.31	0.32	EFTR
VECT	-0.73	-0.44		0.7	-0.45	-0.73	-0.72	0.69	-0.59	-0.41	VECT
AVRO	-0.77	-0.26	0.7		0.06	-0.24	-0.71	0.36	-0.73	-0.36	AVRO
IMMX	0.25	0.5	-0.45	0.06		0.83	0.25	-0.5	0.18	0.3	IMMX
NAVB	0.52	0.57	-0.73	-0.24	0.83		0.44	-0.57	0.39	0.36	NAVB
SONN	0.81	0.24	-0.72	-0.71	0.25	0.44		-0.63	0.8	0.69	SONN
CWBR	-0.5	-0.28	0.69	0.36	-0.5	-0.57	-0.63		-0.46	-0.48	CWBR
OCEA	0.9	0.31	-0.59	-0.73	0.18	0.39	0.8	-0.46		0.75	OCEA
ENVB	0.73	0.32	-0.41	-0.36	0.3	0.36	0.69	-0.48	0.75		ENVB
	ZVSA	EFTR	VECT	AVRO	IMMX	NAVB	SONN	CWBR	OCEA	ENVB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OCEA	+ 0.9	ZVSA
NAVB	+ 0.83	IMMX
SONN	+ 0.81	ZVSA
OCEA	+ 0.8	SONN
ENVB	+ 0.75	OCEA
ENVB	+ 0.73	ZVSA

High negative correlations

AVRO	- 0.77	ZVSA
OCEA	- 0.73	AVRO
NAVB	- 0.73	VECT
VECT	- 0.73	ZVSA
SONN	- 0.72	VECT
SONN	- 0.71	AVRO

Risk-Adjusted Indicators

There is a big difference between Cns Stock performing well and Cns Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cns Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	4.10	(1.47)	0.00	(0.36)	0.00	0.00	7.57	(9.60)	78.93
EFTR	7.57	(4.57)	0.00	(470.75)	0.00	0.00	8.70	(27.78)	88.91
VECT	2.63	0.98	0.54	0.96	0.88	(3.64)	5.61	(3.08)	39.30
AVRO	1.77	0.20	0.01	(0.30)	1.89	(2.24)	4.11	(3.17)	14.20
IMMX	4.25	(0.12)	(0.02)	0.01	4.55	(5.41)	9.38	(8.22)	32.68
NAVB	6.04	(1.01)	0.00	1.31	0.00	0.00	12.50	(12.50)	40.40
SONN	4.77	(0.98)	0.00	1.80	0.00	0.00	12.31	(9.79)	37.58
CWBR	7.34	2.79	0.33	(0.85)	5.34	(11.19)	5.73	(5.59)	250.97
OCEA	3.51	(0.36)	0.00	(0.81)	0.00	0.00	7.46	(6.06)	28.33
ENVB	3.25	(0.61)	0.00	(3.83)	0.00	0.00	6.25	(7.50)	28.33

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC